Abbott 3Q 3Q Revenues: $9.8 billion (-3%) 3Q Earnings: $1.9 billion (3Q11 earnings were $303 million) YTD Revenues: $29.0 billion (+2%) YTD Earnings: $4.9 billion (+58%) Comments: Proprietary pharmaceutical sales dropped 4% in 3Q to $4.4 billion, due to currency fluctuation. U.S. proprietary pharma revenues were up 7% to $2.6 billion. Established pharma revenues dropped 7% to $1.3 billion. For YTD, proprietary pharma revenues were up 2% to $12.9 billion and established pharma revenues down ...